Metabolic
Retatrutide
LY3437943 / Triple agonist
- Peptide length
- 39 amino acids
Acylated peptide analog
Research contextHuman studies exist
Read the linked studies for their methods and limitations.
A triple receptor agonist with randomized human obesity research, including a published phase 2 trial.
- Family
- Multi-receptor incretin analog
- Research frame
- GIP, GLP-1 and glucagon receptors
- Molecular format
- Acylated peptide analog
Read the evidence
Interpret weight changes with trial duration, escalation, discontinuations and comparator in view. Consult the trial register for subsequent development.
Resolve the identity
Distinguish the studied molecule from other triple agonists and from commercially described salts or research preparations.